Sign in
4

Changes in Ownership

UroGen Pharma Ltd. Filed Acc 0001437749-25-020045

Chief Medical Officer sold 5,162 shares at $7.37 ($38,044)

  • Chief Medical Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Schoenberg Mark · Chief Medical Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-06-08 Exercise or conversion : show line 1 in the form +10,000 158,540 D
2025-06-09 Sale : show line 2 in the form −5,162 $7.37 $38,044 153,378 D
Open-market sales · 5,162 sh · avg $7.37 · $38,044

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-06-08 Exercise or conversion : show line 3 in the form Restricted Stock Units −10,000 10,000 D
Loading xslF345X05/rdgdoc.xml…